Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.

× No keyword cloud information.

15 in total

Review 1. Considerations When Treating Hepatitis C in a Cirrhotic Transplant Candidate.

Authors: Kimberly E Daniel; Adnan Said
Journal: Curr Gastroenterol Rep Date: 2018-04-05

Review 2. Management of Hepatitis C in Special Populations: HIV Coinfection, Renal Disease, and Decompensated Cirrhosis.

Authors: Joseph K Lim
Journal: Clin Liver Dis (Hoboken) Date: 2020-07-21

3. HCV Therapy in Decompensated Cirrhosis before or after Liver Transplantation: A Paradoxical Quandary.

Authors: Chalermrat Bunchorntavakul; Rajender K Reddy
Journal: Am J Gastroenterol Date: 2017-12-05 Impact factor: 10.864

4. De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.

Authors: Allison J Kwong; W Ray Kim; Jennifer A Flemming
Journal: Hepatology Date: 2018-10 Impact factor: 17.425

5. Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey.

Authors: Ashton A Shaffer; Alvin G Thomas; Mary Grace Bowring; Sarah E Van Pilsum Rasmussen; Ayla Cash; Lauren M Kucirka; Saleh A Alqahtani; Ahmet Gurakar; Mark S Sulkowski; Andrew M Cameron; Dorry L Segev; Christine M Durand
Journal: Transpl Infect Dis Date: 2018-09-21 Impact factor: 2.228

6. Discovery and Validation of a Biomarker Model (PRESERVE) Predictive of Renal Outcomes After Liver Transplantation.

Authors: Josh Levitsky; Sumeet K Asrani; Goran Klintmalm; Thomas Schiano; Adyr Moss; Kenneth Chavin; Charles Miller; Kexin Guo; Lihui Zhao; Linda W Jennings; Merideth Brown; Brian Armstrong; Michael Abecassis
Journal: Hepatology Date: 2020-01-28 Impact factor: 17.425

7. Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.

Authors: Allison J Kwong; Anji Wall; Marc Melcher; Uerica Wang; Aijaz Ahmed; Aruna Subramanian; Paul Y Kwo
Journal: Am J Transplant Date: 2018-11-26 Impact factor: 8.086

8. Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout.

Authors: Annsa C Huang; Neil Mehta; Jennifer L Dodge; Francis Y Yao; Norah A Terrault
Journal: Hepatology Date: 2018-05-16 Impact factor: 17.425

9. Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant.

Authors: Marion G Peters; Shyam Kottilil; Norah Terrault; Dominic Amara; Jennifer Husson; Shirish Huprikar; Sander Florman; Mark S Sulkowski; Christine M Durand; Anne F Luetkemeyer; Rodney Rogers; Joshua Grab; Brandy Haydel; Emily Blumberg; Lorna Dove; Jean Emond; Kim Olthoff; Coleman Smith; Thomas Fishbein; Henry Masur; Peter G Stock
Journal: Am J Transplant Date: 2020-12-23 Impact factor: 8.086

10. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.

Authors: Alberto Ferrarese; Giacomo Germani; Martina Gambato; Francesco Paolo Russo; Marco Senzolo; Alberto Zanetto; Sarah Shalaby; Umberto Cillo; Giacomo Zanus; Paolo Angeli; Patrizia Burra
Journal: World J Gastroenterol Date: 2018-10-14 Impact factor: 5.742